InvestorLens

TXG — 10X GENOMICS INC

Public company

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying TXG?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
50
Institutional Conviction
Mixed · 3 buying vs 3 selling last quarter
46
Macro Tailwind
Macro conditions are mixed for this sector
56
Why? — Evidence & Confidence ▾

Of 6 tracked investors who changed their TXG position last quarter, 3 bought and 3 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).

Supporting evidence
  • +3 tracked investors added or increased positions last quarter (Steve Cohen, Stanley Druckenmiller, Ken Griffin)
  • +6 tracked investors reported holding TXG at their latest filing
  • +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −3 tracked investors reduced or exited last quarter (3 reduced, 0 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About 10X GENOMICS INC (TXG)

10X GENOMICS INC (TXG) appears in the most recent 13F filings of 6 tracked institutional investors. The largest disclosed position is held by Cathie Wood (ARK Investment Management), valued at $384M. Across recent filings, tracked investors recorded 8 new positions, 15 increased, 13 reduced, and 2 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in TXG

61
/100
Institutional Accumulation
Added / Increased23
Reduced13
Exited2
BearishBullish
Crowded Trade Score™

How many top investors track TXG

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

TXG Ownership Composition

How 10X GENOMICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Growth & Innovation
65% of tracked value
Institutions
6
tracked investors
Total Reported
$588.7M
combined 13F value
Types3
  • Growth & Innovation65.1%
  • Multi-Strategy / Quant32.1%
  • Macro2.7%
Growth & Innovation(1)
65.1%
Multi-Strategy / Quant(3)
32.1%
Macro(2)
2.7%

Tracked investors currently reporting TXG

1 tracked investor has since exited this position — listed separately below.

  • Cathie WoodJun 30, 2026
    ARK Investment Management
    Shares
    10M
    Value
    $383.5M
    % Portfolio
    2.49%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    3M
    Value
    $113.7M
    % Portfolio
    0.01%
  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    1.9M
    Value
    $71M
    % Portfolio
    0.08%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    116.8K
    Value
    $4.5M
    % Portfolio
    0.00%
  • Stanley DruckenmillerJun 30, 2026
    Duquesne Family Office
    Shares
    403.1K
    Value
    $15.5M
    % Portfolio
    0.30%
  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    13.4K
    Value
    $512.8K
    % Portfolio
    0.00%

Previously held TXG

These investors reported TXG in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Paul Tudor JonesTudor Investment Corp32.7K$378.7KJun 30, 2025

Recent activity

Frequently asked questions

How many institutional investors hold TXG?
6 tracked institutional investors disclosed a position in TXG (10X GENOMICS INC) in their most recent 13F filing.
Who is the largest institutional holder of TXG?
Cathie Wood, ARK Investment Management, holds the largest disclosed position in TXG, valued at $384M.
Did institutional ownership of TXG increase or decrease?
Across recent 13F filings, tracked investors recorded 8 new positions, 15 increased, 13 reduced, and 2 fully exited TXG.
Where does this TXG ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.